Dr. Abud Bakri
👤 SpeakerAppearances Over Time
Podcast Appearances
Is there a free lunch?
That's the big question.
Like we kind of talked about earlier, there's always been these medical mishaps that have happened.
So far...
The data is very promising when it comes to GLP-1s and that we are now reversing this rate of chronic disease.
Is it going to stay that way?
That's a good question.
I'm cautiously optimistic when it comes to these medications.
I've been prescribing them since I was a resident in my VA clinic.
I was putting all these vets, you know, 300 pounds on GLP-1s.
They were losing 50, 100 pounds.
Before it was FDA approved for weight loss, we knew that if you put diabetics on this drug, they would lose weight.
thanks to a lot of the bodybuilders, that kind of pioneered that.
When did the bodybuilders first start using GLPs?
Late 2010s.
Wow.
And then the Signal.
I don't think Norvo or Lilly wanted to make these for obesity.
They were focused on making diabetes drugs.
Because if we zoom out even further...